Association between elevated plasma total homocysteine and increased common carotid artery wall thickness

References

• Boushey C J, Beresford S AA, Omenn G S, Motulsky A G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049–57
   PubMed Web of Science ®Google Scholar
• Stampfer M J, Malinow M R, Willett W C, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877–81
   PubMed Web of Science ®Google Scholar
• Malinow M R. Homocysteine and arterial occlusive diseases. J Intern Med 1994; 236: 603–17
   PubMed Web of Science ®Google Scholar
• Selhub J, Jacques P F, Bostom A G, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332: 286–91
   PubMed Web of Science ®Google Scholar
• Brattstrom L E, Hardebo E, Hultberg B L. Moderate homocysteinemia-a possible risk factor for atherosclerotic cerebrovascular disease. Stroke 1984; 15: 1012–6
   PubMed Web of Science ®Google Scholar
• Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T. Plasma sulfhydryl-containing aminoacids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 1989; 79: 139–46
   PubMed Web of Science ®Google Scholar
• Coull B M, Malinow M R, Beamer N, Sexton G, Nordt F, deGarmo P. Elevated plasma homocysteine concentration as a possible independent risk factor for stroke. Stroke 1990; 21: 572–6
   PubMed Web of Science ®Google Scholar
• Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia; an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149–55
   PubMed Web of Science ®Google Scholar
• Malinow M R, Kang S S, Taylor L M, et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989; 79: 1180–8
   PubMed Web of Science ®Google Scholar
• Taylor LM, Jr., Frang R D, Harris EJ, Jr, Porter J M. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vase Surg 1991; 13: 128–36
   PubMed Web of Science ®Google Scholar
• Molgaard J, Malinow M R, Lassvik C, Holm A C, Upson B, Olsson A G. Hyperhomocyst(e)inemia: an independent risk factor for intermittent claudication. J Intern Med 1992; 231: 273–9
   PubMed Web of Science ®Google Scholar
• Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Gnest J, Jr. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 1996; 64: 587–93
   PubMed Web of Science ®Google Scholar
• Berwanger C S, Jeremy J Y, Stansby G. Homocysteine and vascular disease. Br J Surg 1995; 82: 726–31
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Kuulasmaa K. WHO MONICA Project: assessing CHD mortality and morbidity. J Int Epidemiol 1989; 18(Suppl 1)S38–45
   Google Scholar
• Salonen J T, Puska P, Kottke T E. Smoking, blood pressure and serum cholesterol as risk factors of acute myocardial infarction and death among men in Eastern Finland. Eur Heart J 1981; 2: 365–73
   PubMed Web of Science ®Google Scholar
• Verhoef P, Hennekens C H, Malinow M R, Kok F J, Willett W C, Stampfer M J. A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke 1994; 25: 192–430
   Web of Science ®Google Scholar
• Arnesen E, Refsum H, Bonaa K H, Ueland P M, Forde O H, Nordrehaug J E. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995; 24: 704–9
   PubMed Web of Science ®Google Scholar
• Perry I J, Refsum H, Morris R W, Ebrahim S B, Ueland P M, Shaper A G. Prospective study of serum homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395–8
   PubMed Web of Science ®Google Scholar
• Alfthan G, Pekkanen J, Jauhiainen M, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994; 106: 9–19
   PubMed Web of Science ®Google Scholar
• Blankenhorn D H, Selzer R H, Crawford D W, et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two-and four-year reduction of intima-media thickness measured by ultrasound. Circulation 1993; 88: 20–8
   PubMed Web of Science ®Google Scholar
• Selzer R S, Hodis H N, Kwong-Fu H, et al. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 1994; 111: 1–11
   PubMed Web of Science ®Google Scholar
• Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 422: 43–52
   PubMed Web of Science ®Google Scholar
• Malinow M R, Nieto F J, Szklo M, Chambless L E, Bond G. Carotid artery intimai-medial wall thickening and plasma homocysteine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation 1993; 87: 1107–13
   PubMed Web of Science ®Google Scholar
• Boers G H, Smals A G, Trijbels F J, et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709–15
   PubMed Web of Science ®Google Scholar
• Malinow M R. Hyperhomocyst(e)inemia. A common and easily reversible risk factor for atherosclerosis. Circulation 1990; 81: 2004–6
   PubMed Web of Science ®Google Scholar
• Mayer E L, Jacobsen D W, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27: 517–27
   PubMed Web of Science ®Google Scholar
• Starkebaum G, Harlan J M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986; 77: 1370–6
   PubMed Web of Science ®Google Scholar
• Heinecke J W, Rosen H, Suzuki L A, Chait A. The role of sulfur-containing amino acid in superoxide production and modification of low density lipoproteins by arterial smooth muscle cells. J Biol Chem 1987; 262: 98–103
   Web of Science ®Google Scholar
• Steinberg D, Parthasarathy S, Carew T E, Khoo J C, Witztum J L. Beyond cholesterol. Modification of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–24
   PubMed Web of Science ®Google Scholar
• Salonen J T, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339: 883–7
   PubMed Web of Science ®Google Scholar
• Hirano K, Ogihara T, Miki M, et al. Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol. Free Radic Res 1994; 21: 267–76
   PubMed Web of Science ®Google Scholar